Thursday, Apr 18 2024 | Time 12:26 Hrs(IST)
image
Press Releases » PNN


Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Ahmedabad (Gujarat) [India], February 24: Gujarat based Vivanza Biosciences Ltd (BSE - 530057) - engaged in the business of pharmaceuticals and agro trading has reported excellent financial results for the nine months ended December 2023. Company reported consolidated total income of Rs. 23.49 crore for the 9MFY24 with a 137% Y-o-Y growth as compared to total income of Rs. 9.92 crore in nine months of FY23. Net profit of the company also jumped 37% to Rs. 96.13 lakh during 9MFY24 as compared to net profit of Rs. 70.19 crore.

Company has reported strong growth over years with 3 Year CAGR of 23% sales and 69% in Net profits. Going forward, the company aims to fortify its position by strategically expanding its operations, bolstering manufacturing capabilities, and optimizing organizational capacities. The Company is looking at different opportunities in untapped markets and also across a value chain. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units and plans for alliances with business associates in the global market

Vivanza Biosciences Limited is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. Over the last two decades, it has carved for itself, opportunities & faced challenges head on to achieve many milestones. Company offers diversified product portfolio in therapeutic areas including Diabetes, Anti Malaria, Nephrology and Cardiovascular. Company has 100 plus contract manufacturing clients and 32 plus products in pipeline. For FY23, company reported net profit of Rs. 71.6 lakh and Total income of Rs. 18.3 crore.

Earlier in March 2023, company approved stock split in the ration of 1:10. Company approved subdivision of one Equity Share having face value of Rs.10 each into 10 Equity Shares of Rs. 1 each.

The company has further taken major initiatives like strong marketing efforts, focus on cost reduction through inventory management techniques, introduction of new products and manufacturing process without compromising quality of products and retain talented employees etc.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Disclaimer: This is syndicated feed from PR agency and any legal liability for the content is theirs only.

More News
Dr  Payal Kanodia Reveals FICCI YFLO Delhi's Roadmap for Empowering Women

Dr Payal Kanodia Reveals FICCI YFLO Delhi's Roadmap for Empowering Women

17 Apr 2024 | 11:13 PM

New Delhi (India), April 17: Recently, the Young FICCI Ladies Organisation (YFLO), Delhi, the women’s wing of FICCI, has appointed Dr.

see more..

Empowering Entrepreneurs and Igniting Innovation, Juggernautslab Redefines Startup Incubation

17 Apr 2024 | 3:18 PM

Empowering Entrepreneurs and Igniting Innovation, Juggernautslab Redefines Startup Incubation

see more..

Dabur Honey is clinically studied to support health and fitness

17 Apr 2024 | 3:43 PM

Dabur Honey is clinically studied to support health and fitness

see more..

TiE Rajasthan's TiE U Program Empowers College Startups for Fourth Consecutive Year

17 Apr 2024 | 4:09 PM

TiE Rajasthan's TiE U Program Empowers College Startups for Fourth Consecutive Year

see more..

Chipmunk Soars to New Heights, Experiencing Explosive Growth in India's Beauty Market

17 Apr 2024 | 4:35 PM

Chipmunk Soars to New Heights, Experiencing Explosive Growth in India's Beauty Market

see more..
image